Lilly expects to soon announce late-stage clinical trial results for two biotech drugs designed to slow the inflammation caused by autoimmune diseases. By the end of the year, it will announce results for a third.
Indiana University Health plans to construct a new hospital in Bloomington four or five years from now, the Indianapolis-based hospital system announced Wednesday, after striking a deal with Indiana University to build on the school's golf driving range.
U.S. spending on prescription drugs soared last year, driven up primarily by costly breakthrough medicines, manufacturer price hikes and a surge from millions of people newly insured due to the Affordable Care Act.
AIT Labs and its former executives have already incurred nearly $5 million defending themselves against charges by the U.S. Department of Labor that AIT founder Michael Evans sold the company to its employees in 2009 at an inflated price.
By subtly threatening the loss of patients via a new "reference lab network," the Indianapolis-based health insurer has persuaded 63 Indiana hospitals to slash their prices for blood and tissue testing by as much as 80 percent—beyond the discounts Anthem had already negotiated with them.